725 related articles for article (PubMed ID: 9813740)
1. [Atenolol/nifedipine combination: efficacy and tolerability of low dose synergistic bitherapy in the treatment of arterial hypertension].
Krivitzky A; Nguyen G; Gaudouen Y; Legrand M; Cohen R
Drugs; 1998; 56 Suppl 2():31-43. PubMed ID: 9813740
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacologic importance of the combination atenolol/nifedipine in hypertensive patients].
Carré A
Drugs; 1998; 56 Suppl 2():23-30. PubMed ID: 9813739
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of atenolol, nifedipine and their combination in the management of hypertension.
Stanley NN; Thirkettle JL; Varma MP; Larkin H; Heath ID
Drugs; 1988; 35 Suppl 4():29-35. PubMed ID: 3288468
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].
Verdecchia P
Minerva Cardioangiol; 1993 Sep; 41(9):349-63. PubMed ID: 7903118
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of long-acting nifedipine GITS/OROS monotherapy or combination therapy in hypertensive patients: results of a 12-week international, prospective, multicentre, observational study.
Ueng KC; Ningling S; El Maksod A; Hung KY; Yuehui Y
Clin Drug Investig; 2011; 31(9):631-42. PubMed ID: 21591818
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and tolerability of atenolol, nifedipine, and their combination in the management of hypertension.
Stanley NN; Thirkettle JL; Varma MP; Larkin H; Heath ID
Eur J Clin Pharmacol; 1988; 34(6):543-8. PubMed ID: 3049118
[TBL] [Abstract][Full Text] [Related]
7. Aims of combination therapy--improved quality of life or better blood pressure control?
Maclean D
Drugs; 1988; 35 Suppl 4():16-21. PubMed ID: 3378514
[TBL] [Abstract][Full Text] [Related]
8. The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group.
Fox KM; Mulcahy D; Findlay I; Ford I; Dargie HJ
Eur Heart J; 1996 Jan; 17(1):96-103. PubMed ID: 8682138
[TBL] [Abstract][Full Text] [Related]
9. Nitrendipine and atenolol: comparison and combination in the treatment of arterial hypertension.
de Divitiis O; Petitto M; Di Somma S; Galderisi M; Villari B; Santomauro M; Fazio S
Arzneimittelforschung; 1985; 35(4):727-9. PubMed ID: 3160356
[TBL] [Abstract][Full Text] [Related]
10. Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Nifedipine-Atenolol Study Review Committee.
Nifedipine-Atenolol Study Review Committee
Br Med J (Clin Res Ed); 1988 Feb; 296(6620):468-72. PubMed ID: 2894883
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
[TBL] [Abstract][Full Text] [Related]
12. Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone.
Daniels AR; Opie LH
Am J Cardiol; 1986 Apr; 57(11):965-70. PubMed ID: 3515899
[TBL] [Abstract][Full Text] [Related]
13. Calcium antagonists: a review of the recent comparative trials.
Fitzsimons TJ
J Hypertens Suppl; 1987 Aug; 5(3):S11-5. PubMed ID: 2889810
[TBL] [Abstract][Full Text] [Related]
14. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
15. Structure and function of small arteries of essential hypertensive patients following chronic treatment with once-a-day nifedipine.
Schiffrin EL
Cardiology; 1997; 88 Suppl 3():20-6. PubMed ID: 9397289
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the effects of mibefradil and atenolol on regression of left ventricular hypertrophy in hypertensive patients.
Höglund C; Cifkova R; Mimran A; Tenczer J; Watt A; Wilkins MR; Lindberg E
Cardiology; 1998 May; 89(4):263-70. PubMed ID: 9643273
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment of hypertension in the elderly with a combination of atenolol and nifedipine.
Fell PJ
Curr Med Res Opin; 1990; 12(1):66-70. PubMed ID: 2188798
[TBL] [Abstract][Full Text] [Related]
19. Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group.
Dargie HJ; Ford I; Fox KM
Eur Heart J; 1996 Jan; 17(1):104-12. PubMed ID: 8682116
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of atenolol, nifedipine and their combination in the treatment of hypertension.
Smith DH; Neutel JM; Jankelow D; Pretorius JJ; Myburgh DP
S Afr Med J; 1991 Jan; 79(1):12-5. PubMed ID: 1986440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
